Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ADDEX THERAPEUTICS LTD

(ADXN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société ADDEX THERAPEUTICS LTD
06/07ADDEX THERAPEUTICS  : First patients enrolled into multi-center U.S. study (Form..
PU
06/07Addex Starts Phase 2 Clinical Study of ADX71149 for Epilepsy
GL
05/24ADDEX THERAPEUTICS  : to Participate at the Benchmark Company Healthcare House C..
AQ
05/24Addex to Participate at the Benchmark Company Healthcare House Call Conferenc..
GL
05/17Addex's Dipraglurant Restores Synaptic Plasticity in Models of Dystonia
GL
05/14Addex Convenes Annual General Meeting 2021
GL
05/05ADDEX THERAPEUTICS  : Unaudited Condensed Consolidated Financial Statements
PU
05/05Addex Reports Q1 2021 Financial Results and Provides Corporate Update
GL
05/03Addex Therapeutics to Release Q1 2021 Financial Results and Host Conference C..
GL
04/26Addex Increases Issued Share Capital to Create Treasury Shares
GL
04/26Addex to Participate at the 4ᵗʰ Annual Neuroscience Innovation For..
GL
04/13Addex to Present at the 20th Annual Needham Virtual Healthcare Conference
GL
04/08Addex Files Registration Statement on Form F-3 with the US Securities and Exc..
GL
03/11Addex Reports Full Year 2020 Financial Results and Provides Corporate Update
GL
03/09ADDEX THERAPEUTICS  : to Release Full-Year 2020 Financial Results and Host Confe..
AQ
03/04Addex to Present at the H.C. Wainwright Global Life Sciences Conference
GL
02/24ADDEX THERAPEUTICS  : Enamine Extend Collaboration With Prominent Swiss Biotech
BU
02/16ADDEX THERAPEUTICS  : GABAB Positive Allosteric Modulators Demonstrate Promise i..
PU
02/16Addex GABAB Positive Allosteric Modulator Demonstrates Promise in Alcohol Use..
GL
01/12Addex to Present at the Baader Helvea Swiss Equities Conference
GL
01/11Addex Successfully Completes $11.5 Million Capital Increase Including Full Ex..
GL
01/06Addex Announces Pricing of $10.0 Million Global Offering
GL
2020Addex Announces Filing of Registration Statement for Proposed Public Offering..
GL
2020ADDEX THERAPEUTICS  : Quarter 3 Report
PU
2020ADDEX THERAPEUTICS  : Reports Q3 2020 Financial Results and Provides Corporate U..
AQ
2020ADDEX THERAPEUTICS  : Reports Q3 2020 Financial Results and Provides Corporate U..
AQ
2020Addex Reports Q3 2020 Financial Results and Provides Corporate Update
GL
2020ADDEX THERAPEUTICS  : to Report Q3 Financial Results and host Conference Call on..
PU
2020ADDEX THERAPEUTICS  : TO RELEASE Q3 2020 FINANCIAL RESULTS AND HOST CONFERENCE C..
AQ
2020ADDEX THERAPEUTICS  : TO RELEASE Q3 2020 FINANCIAL RESULTS AND HOST CONFERENCE C..
AQ
2020ADDEX THERAPEUTICS TO RELEASE Q3 2020 FINANCIAL RESULTS AND HOST CONFERENCE C..
GL
2020ADDEX THERAPEUTICS  : Receives Additional $2.8 million from Indivior and Extends..
AQ
2020ADDEX THERAPEUTICS  : Receives Additional $2.8 million from Indivior and Extends..
AQ
2020Addex Receives Additional $2.8 million from Indivior and Extends GABAB PAM Re..
GL
2020ADDEX THERAPEUTICS  : to Present at the Investora Conference
AQ
2020ADDEX THERAPEUTICS  : to Present at the Investora Conference
AQ
2020Addex to Present at the Investora Conference
GL
2020ADDEX THERAPEUTICS  : to Participate at the H.C. Wainwright 22nd Annual Global I..
AQ
2020ADDEX THERAPEUTICS  : to Participate at the H.C. Wainwright 22nd Annual Global I..
AQ
2020Addex Therapeutics to Participate at the H.C. Wainwright 22nd Annual Global I..
GL
2020Addex Therapeutics to Participate at the Biotechgate Digital Partnering Confe..
GL
2020Addex and the SIB Swiss Institute of Bioinformatics Receive Innosuisse Grant ..
GL
2020ADDEX THERAPEUTICS  : Reports 2020 Half Year Financial Results and Provides Corp..
AQ
2020Addex Reports 2020 Half Year Financial Results and Provides Corporate Update
GL
2020Addex Therapeutics to Release Half-Year 2020 Financial Results and Host Confe..
GL
2020Addex Therapeutics to Participate in the BTIG Virtual Biotechnology Conferenc..
GL
2020ADDEX THERAPEUTICS  : Van Leeuwenhoeck Issues Updated Addex Equity Research Repo..
AQ
2020ADDEX THERAPEUTICS  : mGlu2 PAM Program to Advance into Epilepsy Phase 2a Proof ..
AQ
2020Addex mGlu2 PAM Program to Advance into Epilepsy Phase 2a Proof of Concept Cl..
GL
2020Addex Shareholders Approve All Resolutions at Annual General Meeting
GL
2020Addex Reports Q1 2020 Financial Results and Provides Corporate Update
GL
2020Addex Therapeutics Establishes Scientific Advisory Board
GL
2020Addex Reports 2019 Full Year Audited Results and Provides Corporate Update
GL
2020Addex Therapeutics to Report 2019 Full Year Audited Results on April 8, 2020
GL
2020ADDEX THERAPEUTICS  : Delays Start of Dipraglurant Pivotal Study and Reporting 2..
PU
2020Addex Therapeutics Delays Start of Dipraglurant Pivotal Study and Reporting ..
GL
2020Addex Therapeutics to Report 2019 Full Year Audited Results on March 19, 2020
GL
2020ADDEX THERAPEUTICS  : Appoints Prominent Neuroscience Drug Developer Darryle D. ..
AQ
2020Addex Therapeutics Appoints Prominent Neuroscience Drug Developer Darryle D. ..
GL
2020Addex Therapeutics to Present at the Cowen and Company 40th Annual Health Car..
GL
2020Addex Therapeutics to Ring the Nasdaq Stock Market Closing Bell
GL
2020ADDEX THERAPEUTICS  : Starts Trading American Depositary Shares on Nasdaq Under ..
AQ
2020ADDEX THERAPEUTICS  : Provides Trading Update and Completes 2019 with Cash Posit..
AQ
2020ADDEX THERAPEUTICS  : to Attend 38th Annual J.P. Morgan Healthcare Conference
AQ
2019ADDEX THERAPEUTICS  : to Receive Additional $800K Funding from Indivior for GABA..
AQ
2019ADDEX THERAPEUTICS  : PUBLICLY FILES REGISTRATION STATEMENT WITH THE U.S. SEC TO..
AQ
2019ADDEX : Van Leeuwenhoeck Issues Update Equity Research Report
AQ
2019Addex Therapeutics Submits Registration Statement with the U.S. SEC to Facili..
GL
2018ADDEX THERAPEUTICS  : Shareholders Approve All Resolutions at Annual General Mee..
GL
2018ADDEX THERAPEUTICS  : Reports 2017 Full Year Results and Provides Corporate Upda..
GL
2018ADDEX THERAPEUTICS  : Sucessfully Raises CHF40 million in Capital Increase
GL
2018ADDEX THERAPEUTICS  : Swiss Takeover Board Validates New Article 39 (Opting-Out ..
GL
2018ADDEX THERAPEUTICS  : Shareholders Approved all Board Proposals at Extraordinary..
GL
2018ADDEX THERAPEUTICS  : Secures Investor Commitment for CHF40 million Capital Incr..
GL
2018ADDEX THERAPEUTICS  : Publishes Extraordinary General Meeting Invitation
GL
1  2  3  4Next
Upcoming event on ADDEX THERAPEUTICS LTD
06/16/21